已收盤 02-06 16:00:00 美东时间
+2.750
+2.58%
今日重点评级关注:Canaccord Genuity:维持Wave Life Sciences Ltd."买入"评级,目标价从40美元升至43美元;花旗:维持Palantir Technologies"买入"评级,目标价从235美元升至260美元
02-04 12:15
Goldman Sachs analyst Lizzie Dove maintains Choice Hotels Intl (NYSE:CHH) with a Neutral and raises the price target from $90 to $100.
02-04 00:41
今日重点评级关注:Guggenheim:维持MBX Biosciences"买入"评级,目标价从77美元升至88美元;摩根士丹利:维持DraftKings"超配"评级,目标价从50美元升至53美元
01-20 10:26
Barclays analyst Anthony Powell maintains Choice Hotels Intl (NYSE:CHH) with a Underweight and lowers the price target from $99 to $98.
01-17 00:01
今日重点评级关注:Needham:维持Cartesian Therapeutics"买入"评级,目标价从40美元升至42美元;Piper Sandler:维持Acrivon Therapeutics"超配"评级,目标价从6美元升至8美元
01-12 14:09
12 analysts have expressed a variety of opinions on Choice Hotels Intl (NYSE:CH...
01-10 03:00
今日重点评级关注:Needham:维持Vaxcyte"买入"评级,目标价从90美元升至110美元;Citizens: 维持LGI Homes"跑赢大市"评级,目标价从85美元升至95美元
01-08 18:33
UBS analyst Robin Farley maintains Choice Hotels Intl (NYSE:CHH) with a Neutral and lowers the price target from $120 to $118.
01-08 04:44
今日重点评级关注:HC Wainwright & Co.:维持BioCryst Pharma"买入"评级,目标价从30美元升至32美元;TD Cowen:上调Milestone Pharmaceuticals评级至"买入",目标价8美元
2025-12-16 09:36
今日重点评级关注:杰富瑞:维持ImmunityBio Inc Ordinary Shares"买入"评级,目标价从8美元升至9美元;B. Riley证券:维持WAVE Life Sciences"买入"评级,目标价从19美元升至37美元
2025-12-15 15:30